Sanjay Kumar Sharma has been appointed as Chief Executive Officer of Biodeal Pharmaceuticals Ltd. In his new role, he will lead the company’s overall strategy, operations, and global expansion initiatives, steering Biodeal towards its next phase of growth and innovation in the pharmaceutical sector.
Sanjay Kumar Sharma brings with him nearly three decades of leadership experience across global pharmaceutical organizations. Prior to joining Biodeal, he served as President – International Sales and Marketing at Synokem Pharmaceuticals Ltd, where he successfully drove business growth and strategic partnerships. He also held senior leadership positions at Cadila Pharmaceuticals Limited as President for Russia, CIS, and Baltic countries, and at Ananta Medicare Limited as Global Business Head.
Sanjay Kumar Sharma has also contributed significantly to international business development through key roles at Unique Pharmaceuticals Limited (J.B. Chemicals & Pharmaceuticals Ltd.), Ipca Laboratories Limited, and Unichem Laboratories Limited. His deep expertise spans international sales and marketing, mergers & acquisitions, regulatory affairs, branded formulations, and business strategy.
Sanjay Kumar Sharma’s extensive global experience across CIS, Baltic, African, and Southeast Asian markets makes him a proven leader in scaling pharmaceutical businesses internationally. His appointment at Biodeal Pharmaceuticals Ltd marks a strategic move to strengthen the company’s global footprint and reinforce its position as a trusted healthcare partner.